HR Execs on the Move

Oral Health Products

www.oralhealthproducts.com

 
Oral Health Products is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

University of Miami Health System

The University of Miami Health System delivers leading-edge patient care by the region`s best doctors, powered by the groundbreaking research of the University of Miami Leonard M. Miller School of Medicine. As South Florida`s only university-based medical system, UHealth is a vital component of the community that is leading the next generation of health care.

Haupt Pharma

Haupt Pharma is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Soredex

Soredex is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Senesco Technologies, Inc.

Senesco Technologies, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New Brunswick, NJ. To find more information about Senesco Technologies, Inc., please visit www.senesco.com

RRD International, LLC

Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).